REFERENCES
- Fathalla MF. Contraception and women’s health. Br Med Bull 1993;49(1):245–51.
- Aitken RJ, Paterson M, Thillai Koothan P. Contraceptive vaccines. Br Med Bull 1993;49(1):88–99.
- Lincoln DW. Contraception for the year 2020. Br Med Bull 1993;49(1)122–36.
- Jones WR. Contraception. Baillieres Clin Obstet Gynaecol 1992;6(3):629–40.
- Dirnhofer S, Klieber R, De Leeuw R, Bidart JM, Merz WE, Wick G, Berger P. Functional and immunological relevance of the COOH-terminal extension of human chorionic gonadotropin B: implications for the WHO birth control vaccine. FASEB J 1993; 7(14):1381–5.
- Roberge LF. Abortifacient Vaccine Technology: Overview, Hazards, and Christian Response. Linacre Quarterly 1995; August: 67–75.
- Dirnhofer S, Wick G, Berger P. The suitability of human chorionic gonadotropin (hCG)-based birth-control vaccines. Immunol Today 1994; 15(10):469–74.
- Vaitukaitis JL, Ross GT, Reichert LE, Ward DN. Immunologic basis for within and between species cross reactivity of luteinizing hormone. Endocrinology 1972;91:1337–42.
- Berger P, Klieber R, Panmoung W, Madersbacher S, Wolf H, Wick G. Monoclonal antibodies against the free subunits of human chorionic gonadotrophin. J Endocrinol 1990;125:301–9.
- Dirnhofer S, Lechner 0, Madersbacher S, Klieber R, de Leeuw R, Wick G, Beyer P. Free a subunit of human chorionic gonadotrophin: molecular basis of immunologically and biologically active domains. J Endocrinol 1994;140:145–54.
- Schwarz S, Berger P, Nelboeck E. et al. J Recept Res 1988;8:437–53.
- Berger P, Dirnhofer S, Klieber R, Frank R, Wick G in Follicle Stimulating Hormone: Regulation of Secretion and Molecular Mechanisms of Action. (Hunzicker-Dunn, Schwartz NB, eds), Springer-Verlag. 1992; pp. 393–9.
- Madersbacher S, Klieber R, Mann K, Marth C, Tabarelli M, Wick G, Berger P. Free a-subunit, free B-subunit of human chorionic gonadotropin (hCG), and intact hCG in sera of healthy individuals and testicular cancer patients. Chin Chem 1992;38:370–6.
- Lei ZM, Toth P, Rao CV, Pridham D. Novel coexpression of human chorionic gonadotropin (hCG)/human leteinizing hormone receptors and their ligand hCG in human fallopian tubes. J Chin Endocrinol Metab 1993; 77:863–72.
- Xiong X, Buekens P, Wollast E. IUD use and the risk of ectopic pregnancy: A meta-analysis of rasP-control studies. Contraception 1995; 52:23–34.
- Richardson A., Paul C. A national study to monitor the safety of IUD use. Contraception 1993;47:359–66.
- Makkonen K. Problems in distribution of scientific knowledge: Intrauterine contraceptive devices and drug catalogs. Int J Health Serv 1993;23:173-83.
- GynoPharma Inc. Patient information for an informed decision: ParaGard T380A Intrauterine Copper Contraceptive. The Corporation, Somerville, NJ. 1991.
- ALZA Corporation. Progestasert: Intrauterine Progesterone Contraceptive System Patient Information. The Corporation, USA. 1989.